Avsnittsbeskrivning
Vivodyne’s Andrei Georgescu explains how vascularized human tissue models, robotics, multi-omic measurement, and foundation models could improve drug testing before clinical trials. Archetype AI’s Nick Gillian discusses Newton, a Physical AI model that combines sensor data to understand and predict events in the real world; the hosts also examine AI product safety, OpenAI and Anthropic’s alignment philosophies, CRISPR research, and whether AI can deliver useful advances in biology before it is fully understood.
Chapters
(0:00) AI safety has two different meanings.
(0:15) Why drug testing…
Webbplats: briefing.ai-in-the-am.com

